|
Home | Medical-Newswire.Com:
|
(EMAILWIRE.COM, January 22, 2009 ) New Delhi, India - The US musckoloskeletal device and implant market was valued at more than US$ 20 Billion in 2008, making up for over 50% of the global market for such devices, according to “Market Potential for Hospital Services, Pharmaceuticals and Medical Devices in US”, a new research report from RNCOS. The market is projected to see a blistering CAGR growth of 11.8% through 2012.
The reconstructive surgery segment, representing 33.5% of the musculoskeletal device and implant market, is expected to be the key booster to the US musculoskeletal device & implant & implant market in the next four years, with Spinal (30.7%) and Fixation (16.0%) playing secondary role in the growth, anticipates the report.
Re-constructive joint implants are likely to continue to represent the largest segment in the reconstructive surgery field primarily due to rising demand for more procedures by increasing elderly population. The positive outlook for joint implants segment is based on figures of 2007 when nearly 663,000 knee replacement procedures and 251,000 hip replacement procedures were successfully performed, according to the report. Further, the number of both hip and knee replacement procedures is expected to surge sharply by 2012, with increasing incidents of knee and hip fractures and decreasing relevance of patientsÂ’ age profile. Patients are opting for such procedures at a much younger age now while earlier they were chosen at much older age.
“Market Potential for Hospital Services, Pharmaceuticals and Medical Devices in US” discusses the past, current and future market scenario by providing factual details along with quality statistical data. The report gives insight into the structure, composition and working of the US healthcare sector and discusses hospital services, pharmaceuticals and medical devices available in the market.
Besides, it contains information on demand, market size and future prospects of all major US healthcare segments such as cardiovascular, in vitro diagnostics, diabetes, dental health, musculoskeletal, cosmetic surgery, oncology and wound care management. It will help the clients to understand key opportunities and challenges that will guide the market in future.
The research study provides forecast on factors like cancer surgery market, biotechnology-based cancer drug market, wound care product market, osteoporosis & low bone mass patients, hip replacement procedures, knee replacement procedures and cardiovascular diseases, and stroke expenditure by type.
For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM147.htm
Check DISCOUNTED REPORTS on http://www.rncos.com
About RNCOS:
RNCOS, incorporated in the year 2002, is an industry research firm. We are a team of industry experts who analyze data collected from credible sources. We provide industry insights and analysis that helps corporations to take timely and accurate business decision in today's globally competitive environment.
RNCOS
Shushmul Maheshwari
91-11-4214-1229
publisher@rncos.com 
Source: EmailWire.com
|
|
|
|
